Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET
Abroad (travel likely)RecruitingPHASE2
Conditions
Essential Thrombocythemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking Union Hospital, Chinese Academy of Medical Sciences, Beijing, China
Peking University People's Hospital, Beijing, China
Union Hospital affiliated to Fujian Medical University, Fujian, China
Nanfang Hospital, Southern Medical University, Guangzhou, China
Harbin First Hospital, Harbin, China
Henan Cancer Hospital, Henan, China
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
The First Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China
Study leads
Lei Zhang
Principal Investigator
Chinese Academy of Medical Sciences